Tobin PJ - Search Results

1

Loperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liver.

Tobin PJ, Hong Y, Seale JP, Rivory LP, McLachlan AJ. Tobin PJ, et al. J Pharm Pharmacol. 2005 Jan;57(1):39-45. doi: 10.1211/0022357055100. J Pharm Pharmacol. 2005. PMID: 15638991

2

The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.

Tobin P, Clarke S, Seale JP, Lee S, Solomon M, Aulds S, Crawford M, Gallagher J, Eyers T, Rivory L. Tobin P, et al. Br J Clin Pharmacol. 2006 Jul;62(1):122-9. doi: 10.1111/j.1365-2125.2005.02477.x. Br J Clin Pharmacol. 2006. PMID: 16842384 Free PMC article.

3

The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model.

Dodds HM, Tobin PJ, Stewart CF, Cheshire P, Hanna S, Houghton P, Rivory LP. Dodds HM, et al. Among authors: tobin pj. J Pharmacol Exp Ther. 2002 Nov;303(2):649-55. doi: 10.1124/jpet.102.039040. J Pharmacol Exp Ther. 2002. PMID: 12388647

4

A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer.

Tobin PJ, Beale P, Noney L, Liddell S, Rivory LP, Clarke S. Tobin PJ, et al. Cancer Chemother Pharmacol. 2006 Feb;57(3):309-16. doi: 10.1007/s00280-005-0053-0. Epub 2005 Jul 8. Cancer Chemother Pharmacol. 2006. PMID: 16003560 Clinical Trial.

5

Inhibition of acetylcholinesterase in patients receiving irinotecan (camptothecin-11).

Tobin P, Rivory L, Clarke S. Tobin P, et al. Clin Pharmacol Ther. 2004 Nov;76(5):505-6; author reply 507-8. doi: 10.1016/j.clpt.2004.07.014. Clin Pharmacol Ther. 2004. PMID: 15536465 No abstract available.

6

The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours.

Tobin PJ, Dodds HM, Clarke S, Schnitzler M, Rivory LP. Tobin PJ, et al. Oncol Rep. 2003 Nov-Dec;10(6):1977-9. Oncol Rep. 2003. PMID: 14534729

7

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

Norris MD, Smith J, Tanabe K, Tobin P, Flemming C, Scheffer GL, Wielinga P, Cohn SL, London WB, Marshall GM, Allen JD, Haber M. Norris MD, et al. Mol Cancer Ther. 2005 Apr;4(4):547-53. doi: 10.1158/1535-7163.MCT-04-0161. Mol Cancer Ther. 2005. PMID: 15827327

8

Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.

Sharma R, Tobin P, Clarke SJ. Sharma R, et al. Lancet Oncol. 2005 Feb;6(2):93-102. doi: 10.1016/S1470-2045(05)01735-3. Lancet Oncol. 2005. PMID: 15683818 Review.

9

Multiphase Veteran Engagement to Develop a Spinal Cord Injury Employment Survey.

Fyffe DC, Cotner BA, Ottomanelli L, Quinn A, Ching D, Clark CT, Tobin PJ, O'Neill J. Fyffe DC, et al. Among authors: tobin pj. Prog Community Health Partnersh. 2023;17(1):13-24. doi: 10.1353/cpr.2023.0006. Prog Community Health Partnersh. 2023. PMID: 37462571

10

Multi-Phase Veteran Engagement to Develop a Spinal Cord Injury Employment Survey.

Fyffe DC, Cotner BA, Ottomanelli L, Quinn A, Ching D, Clark CT, Tobin PJ, O'Neill J. Fyffe DC, et al. Among authors: tobin pj. Prog Community Health Partnersh. 2023;17(1):e3-e4. doi: 10.1353/cpr.2023.0001. Prog Community Health Partnersh. 2023. PMID: 37462566 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters